The clinical and pathological differences between synucleinopathies such as Parkinson’s
disease and multiple system atrophy have been postulated to stem from unique strains of α-…

Background Pompe disease is a rare disorder characterised by progressive loss of muscle
and respiratory function due to acid α-glucosidase deficiency. Enzyme replacement therapy …

Background Multiple system atrophy (MSA) is a neurodegenerative condition characterized
by variable combinations of parkinsonism, autonomic failure, cerebellar ataxia and …

Zinc-finger nuclease (ZFN)-based in vivo genome editing is a novel treatment that can potentially
provide lifelong protein replacement with single intravenous administration. Three first-…

Objective To report and discuss the multi-domain impact of elosulfase alfa, with focus on
tertiary and composite endpoints, in the 24-week, randomized, double-blind, placebo-controlled …

Epilepsy is common in people with intellectual and developmental disabilities (IDD). In
adulthood, patients with IDD and epilepsy (IDD-E) have neurologic, psychiatric, medical, and …

Reminiscent of the human prion diseases, there is considerable clinical and pathological
variability in Alzheimer’s disease, the most common human neurodegenerative condition. As in …

The amyloid cascade hypothesis posits that the initiating event in Alzheimer’s disease (AD)
is the aggregation and deposition of the β-amyloid (Aβ) peptide, which is a proteolytic …

Objective To investigate the efficacy and safety of aceneuramic acid extended-release (Ace-ER),
a treatment intended to replace deficient sialic acid, in patients with GNE myopathy. …

The Gaucher Outcome Survey (GOS) is an international Gaucher disease (GD) registry
established in 2010 for patients with a confirmed GD diagnosis, regardless of GD type or …